Inspra and Hypercholesterolaemia aggravated - a phase IV clinical study of FDA data

Summary:

Hypercholesterolaemia aggravated is reported as a side effect among people who take Inspra (eplerenone), especially for people who are male, 60+ old, also take Lipitor, and have Arrhythmias.

The phase IV clinical study analyzes which people have Hypercholesterolaemia aggravated when taking Inspra. It is created by eHealthMe based on reports of 3,456 people who have side effects when taking Inspra from the FDA, and is updated regularly.

What is Inspra?

Inspra has active ingredients of eplerenone. It is often used in high blood pressure. eHealthMe is studying from 3,510 Inspra users. Check the latest studies of Inspra.

What is Hypercholesterolaemia aggravated?

Hypercholesterolaemia aggravated (high levels of cholesterol in the blood) is found to be associated with 1,498 drugs and 508 conditions by eHealthMe. Check the latest studies of Hypercholesterolaemia aggravated.

On Jul, 11, 2026

3,456 people reported to have side effects when taking Inspra.
Among them, 35 people (1.01%) have Hypercholesterolaemia aggravated.

Could Inspra cause Hypercholesterolaemia aggravated?

Among these 35 people:

What is the gender of people who have Hypercholesterolaemia aggravated when taking Inspra? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Hypercholesterolaemia aggravated when taking Inspra? *

What are other drugs people take besides Inspra? *

What are other side effects people have besides Hypercholesterolaemia aggravated? *

Cardiac Failure Congestive: 15 people, 42.86%
Fatigue (feeling of tiredness): 14 people, 40.00%
Chest Pain: 13 people, 37.14%
Acute Kidney Failure: 13 people, 37.14%
Dyspnea (difficult or laboured breathing): 13 people, 37.14%
Insomnia (sleeplessness): 12 people, 34.29%
Weakness: 12 people, 34.29%
Urinary Tract Infection: 12 people, 34.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 12 people, 34.29%
Sleep Apnea Syndrome: 12 people, 34.29%

What are the existing conditions these people have? *

Arrhythmias (irregular heartbeat): 3 people, 8.57%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.71%
Cardiac Disorder: 2 people, 5.71%
Cardiac Failure: 2 people, 5.71%
Discomfort: 2 people, 5.71%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 2.86%
Hypertriglyceridaemia (excess of triglycerides in the blood): 1 person, 2.86%
Cardiac Failure Congestive: 1 person, 2.86%
Cardiomyopathy (weakening of the heart muscle): 1 person, 2.86%
Cough: 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Inspra and have Hypercholesterolaemia aggravated?

- Check whether Hypercholesterolaemia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Inspra:

Inspra (3,510 reports)

Browse all side effects of Inspra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercholesterolaemia aggravated:

Hypercholesterolaemia aggravated (1,498 drugs)

Browse all the conditions that are associated with Hypercholesterolaemia aggravated:

Hypercholesterolaemia aggravated (508 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eplerenone (the active ingredients of Inspra) and Inspra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.